参考文献/References:
[1]Satake H,Kawada T.Overview of the Primary Structure,Tissue-Distribution,and Functions of Tachykinins and their Receptors[J].Current Drug Targets,2006,7(8):963-974.[2]Garcia-Recio S,Gascón P.Biological and Pharmacological Aspects of the NK1-Receptor[J].BioMed Research International,2015(2015):1-14.[3]Badri H,Smith JA.Emerging targets for cough therapies;NK1 receptor antagonists[J].Pulmonary Pharmacology & Therapeutics,2019(59):101853.[4]Friedman Sheli,Levi-Schaffer Francesca.Substance P and eosinophils:an itchy connection[J].Experimental dermatology,2015,24(12):918-919.[5]Stander S,Yosipovitch G.Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus[J].Br J Dermatol,2019,181(5):932-938.[6]Peng L,Agogo Go,Guo J.et al.Substance P and fibrotic diseases[J].Neuropeptides,2019(76):101941.[7]Muangman P,Tamura RN,Muffley LA.et al.Enhances Wound Closure in Nitric Oxide Synthase Knockout Mice[J].Journal of Surgical Research,2008,153(2):201-209.[8]Chang CT,Jiang BY,Chen CC.Ion Channels Involved in Substance P-Mediated Nociception and Antinociception[J].International Journal of Molecular Sciences,2019,20(7):1596.[9]Li X,Ma G,Ma Q,et al.Neurotransmitter Substance P Mediates Pancreatic Cancer Perineural Invasion via NK-1R in Cancer Cells[J].Molecular Cancer Research,2013,11(3):294-302.[10]王文翔,海静,高玉霞,等,腹腔镜保留盆腔神经的广泛子宫切除治疗子宫肿瘤[J].中华腔镜外科杂志,2016(3):161-164.[11]王玲玲,李飞浪,靳风英.腹腔镜下保留与非保留盆腔神经广泛子宫切除术治疗宫颈癌的临床比较[J].空军医学杂志,2019,35(2):139-142.[12]Feng F,Yang J,Tong L.et al.Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells[J].Cell Biology International,2011(6):623-629.[13]Berger M,Neth O,Ilmer M,et al.Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo[J].J Hepatol,2014,60(5):985-994.[14]Medrano S,Gruenstein E,Dimlich RV.Substance P receptors on human astrocytoma cells are linked to glycogen breakdown[J].Neuroscience Letters,1994,167(1-2):14-18.[15]Munoz M,Covenas R,Esteban F,et al.The substance P/NK-1 receptor system:NK-1 receptor antagonists as anti-cancer drugs[J].J Biosci,2015,40(2):441-463.[16]Mou XZ,Chen X,Ru G,et al.High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis[J].OncoTargets and Therapy,2016.16(9):3595-3602.[17]Karin M,Clevers H.Reparative inflammation takes charge of tissue regeneration[J].Nature,2016,529(7586):307-315.[18]Hursting SD,Berger NA.Energy Balance,Host-Related Factors,and Cancer Progression[J].Journal of Clinical Oncology,2010,28(26):4058-4065.[19]刘华,杨春娟,吴高松,等.NF-κB信号介导的慢性炎症与癌症形成的关系[J].实用药物与临床,2017,20(2):221-223.[20]陈志浩,李政奇,王贵齐.食管腺癌发生发展与慢性炎症的相关性研究[J].中国肿瘤,2017,26(9):721-726.[21]陶华,韦燕珍,王兴民,等.血生物指标在宫颈慢性炎症及其病变中的作用分析研究[J].生殖医学杂志,2017,26(10):1006-1010.[22]Westbrook AM,Szakmary A,Schiestl RH.Mouse models of intestinal inflammation and cancer[J].Archives of Toxicology,2016,90(9):2109-2130.[23]Mashaghi A,Marmalidou A,Tehrani M,et al.Neuropeptide substance P and the immune response[J].Cellular and Molecular Life Sciences,2016,73(22):4249-4264.[24]Dmitrieva OS,Shilovskiy IP,Khaitov MR,et al.Interleukins 1 and 6 as main mediators of inflammation and cancer[J].Biochemistry(Moscow),2016,81(2):80-90.[25]廖二元.胰岛素、胰岛素样生长因子与肿瘤[J].中国糖尿病杂志,2011,19(3):235-237.[26]袁敏生,徐刚,钱立荣.等,胰岛素抵抗激酶[J].中国糖尿病杂志,2001,9(5):303-305.[27]Patro-Malysza J,Kimber-Trojnar Z,Skorzynska-Dziduszko K,et al.The impact of substance P on the pathogenesis of insulin resistance leading to gestational diabetes[J].Curr Pharm Biotechnol,2014,15(1):32-37.[28]Nead KT,Sharp SJ,Thompson DJ,et al.Evidence of a Causal Association Between Insulinemia and Endometrial Cancer:A Mendelian Randomization Analysis[J].J Natl Cancer Inst.2015,107(9):178.[29]Wang LH,Zhou SX,Li RC.et al.Serum Levels of Calcitonin Gene-Related Peptide and Substance P are Decreased in Patients with Diabetes Mellitus and Coronary Artery Disease.Journal of International Medical Research[J].2012,40(1):134-140.[30]童邦菊,卢美松,邓锁,等.P物质在子宫内膜异位症中的表达及其意义[J].现代生物医学进展,2015,15(4):679-681,717.[31]Gharaee N,Pourali L,Jafarian AH.et al.Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer[J].Molecular Biology Reports,2018,45(6):2257-2262.[32]Qi C,Bin-Ya L,Fang-Yuan W,et al.Interleukin 6 promotes endometrial cancer growth through an autocrine feedback loop involving ERK–NF-κB signaling pathway[J].Biochemical and Biophysical Research Communications,2014,446(1):167-172.[33]Harriet O.Smith,Nicole D,et al.The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma[J].Molecular Oncology,2013,7(1):41-54.[34]Ning C,Xie B,Zhang L,et al.Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen[J].Cancer Research,2016,76(6):1354-1366.[35]张琳.M2样肿瘤相关巨噬细胞对胶质瘤血管拟态的影响及机制研究[D].山东大学,2017.[36]Sierra JR,Corso S,Caione L,et al.Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages[J].Journal of Experimental Medicine,2008,205(7):1673-1685.[37]Irahara N,Miyoshi Y,Taguchi T,et al.Quantitative analysis of aromatase mRNA expression derived from various promoters(Ⅰ.4,Ⅰ.3,PⅡ and I.7)and its association with expression of TNF-alpha,IL-6 and COX-2 mRNAs in human breast cancer[J].Int J Cancer,2006,118(8):1915-1921.